FSHR and ovarian carcinoma: Other conceivable molecules for targeting ovarian cancer cells include follicle-stimulating hormone receptor (FSHR) [17], intercellular adhesion molecule 1 (ICAM-1) [18], Müllerian inhibiting substance type II receptor (MISIIR) [19], and human epidermal growth factor receptor 2 (HER2) [20].